Form 8-K - Current report:
SEC Accession No. 0001829126-24-007451
Filing Date
2024-11-13
Accepted
2024-11-13 08:45:25
Documents
14
Period of Report
2024-11-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zeoscientifix_8k.htm   iXBRL 8-K 35050
2 EXHIBIT 99.1 zeoscientifix_ex99-1.htm EX-99.1 15033
  Complete submission text file 0001829126-24-007451.txt   223099

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocel-20241113.xsd EX-101.SCH 2991
4 XBRL LABEL FILE ocel-20241113_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ocel-20241113_pre.xml EX-101.PRE 22343
16 EXTRACTED XBRL INSTANCE DOCUMENT zeoscientifix_8k_htm.xml XML 3346
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Zeo ScientifiX, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 241451374
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)